Methylenetetrahydrofolate reductase gene polymorphisms in children with attention deficit hyperactivity disorder

International Journal of Medical Sciences

Volumn 8, Issue 7, 2011, Pages 523-528

  Gokcen, Cem ^a   Kocak, Nadir ^b   Pekgor, Ahmet ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Attention deficit hyperactivity disorder; Folic acide; Methylenetetrahydrofolate reductase gene polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AGE DISTRIBUTION; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ETHNIC GROUP; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MALE; MTHFR GENE; SCHOOL CHILD; SEX RATIO;

EID: 80054726051     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.523     Document Type: Article

References (35)

1. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry. 2007; 164: 942-8.
2. Leibson CL, Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without at-tention-deficit/hyperactivity disorder. Journal of the American Medical Association. 2001; 285: 60-6.
3. Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Ar-chives of Disease in Childhood. 2005; 90(S1): 2-7.
4. Barkley RA. Attention Deficit/Hyperativity Disorder. A Handbook for Diagnosis and Treatment. 2nd ed. New York, NY: Guilford Press; 1998.
5. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention deficit/hyperactivity disorder. Biological Psychiatry. 2005; 57:1313-23.
6. Goyette P, Sumner JS, Milos R, et al. Human ethylenetetrahy-drofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet. 1994; 7(2):195-200.
7. Cantoni GL. S-Anenysylmethionine: a new intermediate formed enzymatically from 1-methionine and adenosine tri-phosphate. J Biol Chem. 1953; 204:403-16.
8. Lucock M. Folic acid: nutritional biochemistry, molecular biol-ogy, and role in disease processes. Mol Genet Metab. 2000; 71:121-38.
9. Rozen R. Moleculer genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis. 1996; 19:589-94.
10. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahy-drofolate reductase. Nat Genet 1995; 10:111-3.
11. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A->C poly-morphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Ather-osclerosis. 2001; 156:409-15.
12. Molloy AM, Daly S, Mills JL, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet. 1997; 349:1591-3.
13. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review. Am J Epidemiol. 2007; 165:1-13.
14. Wullner U, Kolsch H, Linnebank M. Methylenetetrahydrofolate reductase in Parkinson's disease. Ann Neurol. 2005; 58: 972-3.
15. Wang B, Jin F, Kan R, et al. Association of MTHFR gene poly-morphism C677T with susceptibility to late-onset Alzheimer's disease. J Mol Neurosci. 2005; 27: 23-7.
16. Yoo J, Choi G, Kang S. Pathogenicity of thermolabile methyl-enetetrahydrofolate reductase for vascular dementia. Arterio-scler Thromb Vasc Biol. 2000; 20: 921-5.
17. Boris M, Goldblatt A, Galanko J, et al. Association of MTHFR Gene Variants with Autism. Journal of American Physicians and Surgeons. 2004; 9: 106-8.
18. Schlotz W, Jones A, Phillips DI, et al. Lower maternal folate status in early pregnancy is associated with childhood hyper-activity and peer problems in offspring. J Child Psychol Psychiatry. 2010; 51-5: 594-602.
19. Julvez J, Fortuny J, Mendez M, et al. Maternal use of folic acid supplements during pregnancy and four-year-old neurode-velopment in a population-based birth cohort. Paediatr Perinat Epidemiol. 2009; 23: 199-206.
20. Krull KR, Brouwers P, Jain N, et al. Folate Pathway Genetic Polymorphisms are Related to Attention Disorders in Child-hood Leukemia Survivors. J Pediatr. 2008 Jan; 152(1):101-5.
21. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (KSADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997; 36: 980-8.
22. DuPaul GJ, Anastapoulos AD, Power TJ, et al. Parent ratings of attention deficit hyperactivity disorder: Factor structure, nor-mative data, and psychometric properties. J Psychopathol Be-hav Assess. 1998;: 83-102.
23. Wechsler D. Manual for the Wechsler Intelligence Scale for Children-Revised. New York: Psychological Corporation, 1974.
24. Roffman JL, Weiss AP, Deckersbach T, et al. Effects of the methylenetetrahydrofolate reductase C677T polymorphism on executive function in schizophrenia. Schizophrenia Research. 2007; 92:181-8.
25. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ 2002; 324: 1512-5.
26. Iskandar BJ, Nelson A, Resnick D, et al. Folic acid supplemen-tation enhances repair in the adult central nervous system. Ann Neurol. 2004; 56: 221-7.
27. Friso S, Choi S-W. Gene nutrient interactions and DNA meth-ylation. J Nutr 2002; 132: 2382S-7S.
28. Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003; 26:137-46.
29. Goodwin JS, Goodwin JM, Garry PJ. Association between nu-tritional status and cognitive functioning in a healthy elderly population. JAMA. 1983; 249:2917-21.
30. Craciunescu CN, Brown EC, Mar MH, et al. Folic acid defi-ciency during late gestation decreases progenitor cell prolifera-tion and increases apoptosis in fetal mouse brain. Journal of Nutrition. 2004; 134:162-6.
31. Ferguson SA, Berry KJ, Hansen DK, et al. Behavioral effects of prenatal folate deficiency in mice. Birth Defects Res A Clin Mol Teratol. 2005; 73:249-52.
32. Faraone SV, Mick E. Moleculer Genetics of Attention Deficit Hyperactivity Disorder. Psychiatr Clin North Am. 2010; 33:159-80.
33. Rice D, Barone S Jr. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environmental Health Perspectives. 2000; 108:511-33.
34. del Rio Garcia C, Torres-Sanchez L, Chen J, et al. Maternal MTHFR 677C>T genotype and dietary intake of folate and vitamin B(12): their impact on child neurodevelopment. Nutr Neurosci. 2009; 12:13-20.
35. Wolraich ML, Hannah JN, Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996; 35:319-24.